111 Inc
NASDAQ:YI
111 Inc
Operating Expenses
111 Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Operating Expenses
-¥1.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Operating Expenses
-¥7.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Operating Expenses
-¥5.8B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Operating Expenses
-¥2.1B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Operating Expenses
-¥6.6B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Operating Expenses
-¥4.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Operating Expenses?
Operating Expenses
-1.2B
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Operating Expenses amounts to -1.2B CNY.
What is 111 Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-19%
Over the last year, the Operating Expenses growth was 1%. The average annual Operating Expenses growth rates for 111 Inc have been -13% over the past three years , -19% over the past five years .